News

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...
EurekAlert!2d
Advanced imaging reveals mechanisms that cause autoimmune disease
Those who suffer myasthenia gravis experience muscle weakness that can affect the muscles we use to blink, smile and move our ...
Le Lézard6d
NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...
Medical Dialogues6d
Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment
Vividion Therapeutics, Inc. has announced that the first patient has been dosed in a Phase I clinical trial evaluating ...
Pharmabiz6d
Vividion Therapeutics doses first patient in phase I study of RAS-PI3Ka inhibitor to treat advanced solid tumours
San Diego, California Friday, April 4, 2025, 16:00 Hrs [IST] ...
PipelineReview.com6d
Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors
SAN DIEGO, CA, USA & BERLIN, Germany I April 03, 2025 I Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a ...
American Association of Individual Investors6d
Which Is a Better Investment, Halozyme Therapeutics, Inc. or Moderna, Inc. Stock?
Learn more about whether Halozyme Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
American Association of Individual Investors6d
Which Is a Better Investment, ACADIA Pharmaceuticals Inc. or Moderna, Inc. Stock?
Learn more about whether ACADIA Pharmaceuticals Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.